Abstract
INTRODUCTION
System level barriers have been associated with inadequate follow-up of abnormal cervical cytology.
OBJECTIVE
The aim of this study was to develop and evaluate an electronic tracking system to improve follow-up of abnormal Pap tests.
PROGRAM DESCRIPTION
We implemented an electronic medical record (EMR)-based Pap test tracking system at two clinical practices at an inner-city academic health center. The system generated a provider-specific monthly report of all abnormal Pap results, and provided a patient-specific Pap tracking table embedded in the EMR for each subject.
EVALUATION
We compared abnormal Pap test follow-up rates for the 24 months pre-intervention with rates 12 months following its implementation (post-intervention). The evaluation followed all subjects for 12 months from the date of their abnormal Pap test, looking for diagnostic resolution.
RESULTS
Subjects were young women (mean age = 30.5) of primarily white (42%) and African American (37%) descent, who spoke English (88%). Forty-eight percent were insured through publicly subsidized insurance. Controlling for type of abnormality and practice location, the adjusted mean time to resolution decreased significantly from 108 days (confidence interval, CI 105–112 days) in the pre-intervention period to 86 days (CI 81–91 days).
CONCLUSION
Our study cannot demonstrate that with follow up, we directly avoided cases of invasive cervical cancer. However, we show that in an at-risk urban population, an automated, EMR-based tracking system reduced the time to resolution, and increased the number of women who achieved diagnostic resolution.
Similar content being viewed by others
References
The American Cancer Society. What Are the Key Statistics About Cervical Cancer? http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_cervical_cancer_8.asp. Accessed January 28, 2010.
Schiffman MH, Brinton LA, Devesa SS. Cervical cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996:1090–116.
Peterson NB, Han J, Freund KM. Inadequate follow-up for abnormal Pap smears in an urban population. J Natl Med Assoc. 2003;95(9):825–32.
Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675–83.
Marcus AC, Crane LA, Kaplan CP, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care. 1992;30(3):216–30.
Cartwight PS, Reed G. No-show behavior in a county hospital clinic. Am J Gynecol Health. 1990;6:15–21.
Laedtke TW, Dignan M. Compliance with therapy for cervical dysplasia among women of low socioeconomic status. South Med J. 1992;85(1):5–8.
Lane DS. Compliance with referrals from a cancer-screening project. J Fam Pract. 1983;17(5):811–7.
Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract. 1993;37(6):583–7.
Nathoo V. Investigation of non-responders at a cervical cancer screening clinic in Manchester. Br Med J (Clin Res Ed). 1988;296(6628):1041–2.
Paskett ED, White E, Carter WB, Chu J. Improving follow-up after an abnormal Pap smear: a randomized controlled trial. Prev Med. 1990;19(6):630–41.
Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008;113(12):3391–9.
Townsend RW. Formation and operation of a captive insurance company for malpractice coverage. Coll Rev. 1988;5:47–61.
National Committee for Quality Assurance (NCQA). Standards and Guidelines for Physician Practice Connections - Patient-Centered Medical Home (PPC-PCMH): 2008.
Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002;22(4 Suppl):15–38.
Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007;109(2 Suppl):359–67.
Acknowledgements
Financial support for this study was provided by a grant from the Risk Management Fund at Boston Medical Center. This study was supported by Boston University School of Medicine, Boston, MA. Preliminary data were presented at the 2009 Annual Meeting of the Society of General Internal Medicine in Miami as a poster presentation.
Conflict of Interest
None disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dupuis, E.A., White, H.F., Newman, D. et al. Tracking Abnormal Cervical Cancer Screening: Evaluation of an EMR-Based Intervention. J GEN INTERN MED 25, 575–580 (2010). https://doi.org/10.1007/s11606-010-1287-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-010-1287-z